Eversept Partners’s Pacific Biosciences PACB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$540K Buy
+228,007
New +$322K 0.03% 102

Other funds holding PACB

Eversept Partners's PACB Position: Q3 2026 in Review

Eversept Partners opened a new position in Pacific Biosciences (PACB) in Q3 2026: 228,007 shares worth $540K. The stake represents 0.03% of the portfolio and ranks #102 among its holdings.

204 funds tracked by Wall St. Rank hold PACB as of Q3 2026.

  • Eversept Partners held 228,007 shares of Pacific Biosciences worth $540K as of Q3 2026.
  • Pacific Biosciences was a new Eversept Partners position in Q3 2026.
  • Pacific Biosciences made up 0.03% of Eversept Partners's portfolio in Q3 2026, its #102 holding.
  • 204 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2026.

Based on Eversept Partners's 13F filing for Q3 2026, filed 16 Nov 2026.